Skip to content
10-Q

Quarterly Report

Aspira Women's Health Inc. AWHL

0000926617-26-000033

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 43.5M sh
Shares Diluted Q1 2026 · Mar 31, 2026 45.77M sh
Shares Diluted Q1 2026 · Mar 31, 2025 21.59M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$359K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$3.1M
Long Term Debt Q1 2026 · Mar 31, 2026 $980K
Long Term Debt Q1 2026 · Dec 31, 2025 $1.04M
Short Term Debt Q1 2026 · Mar 31, 2026 $1.87M
Short Term Debt Q1 2026 · Dec 31, 2025 $493K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.34M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.76M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$6.21M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$6.93M
Current Liabilities Q1 2026 · Mar 31, 2026 $5.6M
Current Liabilities Q1 2026 · Dec 31, 2025 $3.47M
Total Liabilities Q1 2026 · Mar 31, 2026 $11.3M
Total Liabilities Q1 2026 · Dec 31, 2025 $12.39M
Current Assets Q1 2026 · Mar 31, 2026 $3.79M
Current Assets Q1 2026 · Dec 31, 2025 $4.06M
Total Assets Q1 2026 · Mar 31, 2026 $5.09M
Total Assets Q1 2026 · Dec 31, 2025 $5.46M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.05
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.09
Eps Basic Q1 2026 · Mar 31, 2026 $0.02
Eps Basic Q1 2026 · Mar 31, 2025 −$0.09
Sga Expense Q1 2026 · Mar 31, 2026 $1.51M
Sga Expense Q1 2026 · Mar 31, 2025 $2.74M
Rd Expense Q1 2026 · Mar 31, 2026 $1.23M
Rd Expense Q1 2026 · Mar 31, 2025 $973K
Net Income Q1 2026 · Mar 31, 2026 $676K
Net Income Q1 2026 · Mar 31, 2025 −$1.85M
Operating Income Q1 2026 · Mar 31, 2026 −$2.2M
Operating Income Q1 2026 · Mar 31, 2025 −$3.24M
Gross Profit Q1 2026 · Mar 31, 2026 $1.07M
Gross Profit Q1 2026 · Mar 31, 2025 $1.56M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $896K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $719K
Revenue Q1 2026 · Mar 31, 2026 $1.97M
Revenue Q1 2026 · Mar 31, 2025 $2.28M